Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Regulatory News (RENE)

  • There is currently no data for RENE

Director/PDMR Shareholding

7 Dec 2006 07:02

ReNeuron Group plc07 December 2006 Director Share Purchases Guildford, UK, 6 December 2006: ReNeuron Group plc (LSE: RENE) today announcesthe following purchases of ordinary shares in ReNeuron by directors of theCompany at 19.5p per share. Name Number of Shares Purchased Michael Hunt 51500John Sinden 36000Mark Docherty 51400(1)Trevor Jones 25700Paul Harper 57500 Following these purchases the directors of ReNeuron have the following interestsin issued ordinary shares in ReNeuron: Name Number of shares Percentage of issued share capitalMichael Hunt 174,613 0.18%John Sinden 1,219,925(2) 1.22%Mark Docherty 146,400(3) 0.15%Trevor Jones 83,200 0.08%Paul Harper 83,200 0.08% The current issued ordinary share capital of the Company is 99,604,700 shares. (1) = including 24,700 ordinary shares acquired by the MD FURBS, a funded unapproved retirement benefit scheme established by Mark Docherty (2) = in addition John Sinden holds 117,160 ordinary shares on trust for family members (3) = including 120,700 ordinary shares held by the MD FURBS, a funded unapproved retirement benefit scheme established by Mark Docherty ENDS Enquiries: ReNeuronMichael Hunt, CEO Tel: 44 (0)1483 302 560John Sinden, CSO Financial DynamicsDavid Yates Tel: 44 (0)20 7831 3113Nicola Daley This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th Jun 200912:17 pmRNSNotice of Results
12th Jun 20092:56 pmRNSHolding(s) in Company
9th Jun 20097:00 amRNSStem cells manufacturing contract signed
21st May 20098:43 amRNSHolding(s) in Company
19th May 20091:21 pmRNSHolding(s) in Company
19th May 20091:18 pmRNSHolding(s) in Company
18th May 20091:06 pmRNSHolding(s) in Company
18th May 20097:00 amRNSFinal Closing of the Placing
14th May 20093:02 pmRNSThird Closing Of The Placing
14th May 200910:43 amRNSRegulatory update
1st May 20097:00 amRNSReN001 data to be presented at US conference
9th Apr 20097:00 amRNSSuccessful automation of stem cell manufacturing
8th Apr 20099:51 amRNSHolding(s) in Company
8th Apr 20099:43 amRNSHolding(s) in Company
7th Apr 20097:00 amRNSSecond Closing of the Placing
6th Apr 20097:00 amRNSPositive pre-clinical data with CTX stem cell line
3rd Apr 200911:19 amRNSResult of EGM and First Closing of the Placing
12th Mar 20097:00 amRNSAnnounces Fundraising and Conversion of Loan Notes
24th Feb 20094:03 pmRNSHolding(s) in Company
26th Jan 20097:00 amRNSReNeuron licenses stem cell line to BioFocus DPI
21st Jan 20097:00 amRNSReNeuron clarifies press comments
19th Jan 20094:00 pmRNSUpdate on ReNeuron's clinical trial
19th Jan 20097:00 amRNSReNeuron gains approval to commence trial
28th Nov 20087:00 amRNSInterim Results
24th Nov 20087:00 amRNSAppointment of NED
14th Nov 20083:30 pmRNSResearch Update
19th Sep 200810:46 amRNSResult of AGM
19th Sep 20087:00 amRNSAGM Statement
7th Aug 20083:33 pmRNSAnnual Report and Accounts
15th Jul 20087:00 amRNSResearch Update
24th Jun 20087:00 amRNSFinal Results
24th Jun 20087:00 amRNSRe: Fund Raising
23rd Jun 20083:38 pmRNSHolding(s) in Company
19th Jun 20084:33 pmRNSNotice of Results
11th Jun 20087:00 amRNSRe: ISSCR Conference
29th May 20087:00 amRNSRe: Contract
21st May 20087:00 amRNSNotice of US Patent Grant
20th May 200810:46 amRNSRe: UK Government Vote
23rd Apr 20087:00 amRNSResearch Update
19th Mar 20087:00 amRNSRegulatory Update
1st Feb 20087:01 amRNSResearch Update
7th Jan 20081:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20081:28 pmRNSRegulatory Update
11th Dec 20077:00 amRNSTo Present at Conference
28th Nov 200711:25 amRNSTo Present at US Conference
28th Nov 200711:13 amRNSNotice of Results
21st Nov 200711:30 amRNSResearch Update
8th Nov 20077:30 amRNSContract with ReNeuron
18th Oct 20077:01 amRNSResearch Update
6th Sep 200711:12 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.